Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis

Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis

Abstract Background We explored whether clinically relevant baseline characteristics of patients with type 2 diabetes can modify the effect of glucagon-like peptide-1 receptor agonists (GLP-1 RA) or sodium-glucose cotransporter-2 inhibitors (SGLT-2i) on the risk of major adverse cardiovascular event...

Full description

Bibliographic Details
Main Authors: Elvira D’Andrea, Aaron S. Kesselheim, Jessica M. Franklin, Emily H. Jung, Spencer Phillips Hey, Elisabetta Patorno
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Cardiovascular Diabetology
Subjects:
Cardiovascular diseases
Diabetes mellitus, type 2
Glucagon-like peptide 1 receptor agonists
Meta-analysis
Sodium-glucose co
Transporter-2 inhibitors
Online Access:http://link.springer.com/article/10.1186/s12933-020-01133-1

Internet

http://link.springer.com/article/10.1186/s12933-020-01133-1

Similar Items